CA1244017A - Method for preparing 6-chloro-n-methyl-2,3,4,5- tetrahydro-1h-3-benzazepine - Google Patents
Method for preparing 6-chloro-n-methyl-2,3,4,5- tetrahydro-1h-3-benzazepineInfo
- Publication number
- CA1244017A CA1244017A CA000488976A CA488976A CA1244017A CA 1244017 A CA1244017 A CA 1244017A CA 000488976 A CA000488976 A CA 000488976A CA 488976 A CA488976 A CA 488976A CA 1244017 A CA1244017 A CA 1244017A
- Authority
- CA
- Canada
- Prior art keywords
- methyl
- benzazepine
- tetrahydro
- chloro
- trichlorobenzene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- RSRUDTPYRBLHEO-UHFFFAOYSA-N Benalfocin Chemical compound C1CN(C)CCC2=CC=CC(Cl)=C21 RSRUDTPYRBLHEO-UHFFFAOYSA-N 0.000 title claims abstract description 5
- 238000000034 method Methods 0.000 title claims description 20
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims abstract description 26
- RELMFMZEBKVZJC-UHFFFAOYSA-N 1,2,3-trichlorobenzene Chemical compound ClC1=CC=CC(Cl)=C1Cl RELMFMZEBKVZJC-UHFFFAOYSA-N 0.000 claims abstract description 10
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims description 9
- PBKONEOXTCPAFI-UHFFFAOYSA-N 1,2,4-trichlorobenzene Chemical compound ClC1=CC=C(Cl)C(Cl)=C1 PBKONEOXTCPAFI-UHFFFAOYSA-N 0.000 claims description 8
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 claims description 3
- VKPPFDPXZWFDFA-UHFFFAOYSA-N 2-chloroethanamine Chemical compound NCCCl VKPPFDPXZWFDFA-UHFFFAOYSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- MWVMYAWMFTVYED-UHFFFAOYSA-N 2,3,4,5-tetrahydro-1h-3-benzazepine Chemical compound C1CNCCC2=CC=CC=C21 MWVMYAWMFTVYED-UHFFFAOYSA-N 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- 239000002904 solvent Substances 0.000 description 7
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000007363 ring formation reaction Methods 0.000 description 3
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- -1 i.e. Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- LIELBBMDHOZRFL-UHFFFAOYSA-N 3-methyl-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1CN(C)CCC2=CC=CC=C21 LIELBBMDHOZRFL-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- AZYXRMVCBUOJSZ-UHFFFAOYSA-N 6-chloro-1-methyl-1-benzazepine;hydrochloride Chemical compound Cl.CN1C=CC=CC2=C(Cl)C=CC=C12 AZYXRMVCBUOJSZ-UHFFFAOYSA-N 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000670 adrenergic alpha-2 receptor antagonist Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 238000010936 aqueous wash Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000005792 cardiovascular activity Effects 0.000 description 1
- 239000012320 chlorinating reagent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 239000005555 hypertensive agent Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229950011008 tetrachloroethylene Drugs 0.000 description 1
- 150000003526 tetrahydroisoquinolines Chemical class 0.000 description 1
- PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/647,552 US4541954A (en) | 1984-09-05 | 1984-09-05 | Method for preparing 6-chloro-N-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
| US647,552 | 1984-09-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1244017A true CA1244017A (en) | 1988-11-01 |
Family
ID=24597406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000488976A Expired CA1244017A (en) | 1984-09-05 | 1985-08-19 | Method for preparing 6-chloro-n-methyl-2,3,4,5- tetrahydro-1h-3-benzazepine |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4541954A (enEXAMPLES) |
| EP (1) | EP0174118A3 (enEXAMPLES) |
| JP (1) | JPS6168469A (enEXAMPLES) |
| KR (1) | KR860002470A (enEXAMPLES) |
| AU (1) | AU581918B2 (enEXAMPLES) |
| CA (1) | CA1244017A (enEXAMPLES) |
| DK (1) | DK379985A (enEXAMPLES) |
| EG (1) | EG17149A (enEXAMPLES) |
| ES (1) | ES8609266A1 (enEXAMPLES) |
| FI (1) | FI853255A7 (enEXAMPLES) |
| GR (1) | GR852041B (enEXAMPLES) |
| HU (1) | HU194181B (enEXAMPLES) |
| IL (1) | IL76100A0 (enEXAMPLES) |
| NO (1) | NO853255L (enEXAMPLES) |
| NZ (1) | NZ213141A (enEXAMPLES) |
| PH (1) | PH20796A (enEXAMPLES) |
| PT (1) | PT81018B (enEXAMPLES) |
| ZA (1) | ZA856268B (enEXAMPLES) |
| ZW (1) | ZW13385A1 (enEXAMPLES) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993000811A1 (en) * | 1991-07-01 | 1993-01-21 | The General Hospital Corporation | Invertebrate phenylethanolamine transporter and the use thereof |
| US5401595A (en) * | 1991-12-06 | 1995-03-28 | Yuasa Corporation | Film type battery and layer-built film type battery |
| US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
| JP4920409B2 (ja) * | 2003-06-17 | 2012-04-18 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ３−ベンズアゼピンを調製する方法 |
| US7704993B2 (en) | 2003-06-17 | 2010-04-27 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| KR101281919B1 (ko) | 2004-12-21 | 2013-07-03 | 아레나 파마슈티칼스, 인크. | (ｒ)-8-클로로-1-메틸-2,3,4,5-테트라히드로-1ｈ-3-벤즈아제핀 히드로클로라이드의 결정질 형태 |
| EP2322162A1 (en) * | 2004-12-23 | 2011-05-18 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulator compositions and methods of use |
| WO2007120517A2 (en) | 2006-04-03 | 2007-10-25 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto |
| JP5404414B2 (ja) * | 2006-12-05 | 2014-01-29 | アリーナ ファーマシューティカルズ， インコーポレイテッド | （ｒ）−８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンゾアゼピンおよびその中間体を調製するための方法 |
| US8822727B2 (en) * | 2008-03-04 | 2014-09-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
| WO2010148207A2 (en) | 2009-06-18 | 2010-12-23 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-ht2c receptor agonists |
| KR20130112848A (ko) | 2010-06-02 | 2013-10-14 | 아레나 파마슈티칼스, 인크. | 5-ｈｔ2ｃ 수용체 아고니스트의 제조 방법 |
| US9365521B2 (en) | 2010-09-01 | 2016-06-14 | Arena Pharmaceuticals, Inc. | Non-hygroscopic salts of 5-HT2C agonists |
| JP2013539470A (ja) | 2010-09-01 | 2013-10-24 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ロルカセリンと光学活性な酸との塩 |
| NZ608266A (en) | 2010-09-01 | 2015-09-25 | Arena Pharm Inc | Administration of lorcaserin to individuals with renal impairment |
| SG10201506874UA (en) | 2010-09-01 | 2015-10-29 | Arena Pharm Inc | Modified-release dosage forms of 5-ht2c agonists useful for weight management |
| AR088670A1 (es) | 2012-10-09 | 2014-06-25 | Arena Pharm Inc | Metodo de control del peso |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1118688A (en) * | 1967-02-17 | 1968-07-03 | Scherico Ltd | Novel benzazepines and process for making same |
| CH481110A (de) * | 1967-02-17 | 1969-11-15 | Geigy Ag J R | Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen |
| US4251660A (en) * | 1978-08-10 | 1981-02-17 | Smithkline Corporation | Method for preparing tetrahydroisoquinolines |
| US4200754A (en) * | 1979-02-02 | 1980-04-29 | Smithkline Corporation | Method for preparing 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline |
| ZA827887B (en) * | 1981-11-27 | 1983-11-30 | Smithkline Beckman Corp | Pharmaceutical compositions and method of producing alpha2 antagonism |
| IE53962B1 (en) * | 1981-11-27 | 1989-04-26 | Smithkline Beckman Corp | 3-benzazepines as alpha-2 antagonists |
| EP0161350A1 (en) * | 1981-11-27 | 1985-11-21 | Smithkline Beckman Corporation | Process for preparing benzazepines |
-
1984
- 1984-09-05 US US06/647,552 patent/US4541954A/en not_active Expired - Fee Related
-
1985
- 1985-08-14 EP EP85305780A patent/EP0174118A3/en not_active Ceased
- 1985-08-15 IL IL76100A patent/IL76100A0/xx unknown
- 1985-08-19 ZA ZA856268A patent/ZA856268B/xx unknown
- 1985-08-19 PH PH32660A patent/PH20796A/en unknown
- 1985-08-19 NO NO853255A patent/NO853255L/no unknown
- 1985-08-19 NZ NZ213141A patent/NZ213141A/xx unknown
- 1985-08-19 CA CA000488976A patent/CA1244017A/en not_active Expired
- 1985-08-20 ES ES546285A patent/ES8609266A1/es not_active Expired
- 1985-08-20 JP JP60183788A patent/JPS6168469A/ja active Pending
- 1985-08-20 ZW ZW133/85A patent/ZW13385A1/xx unknown
- 1985-08-21 AU AU46481/85A patent/AU581918B2/en not_active Ceased
- 1985-08-21 HU HU853190A patent/HU194181B/hu unknown
- 1985-08-21 DK DK379985A patent/DK379985A/da not_active Application Discontinuation
- 1985-08-22 GR GR852041A patent/GR852041B/el unknown
- 1985-08-22 KR KR1019850006061A patent/KR860002470A/ko not_active Withdrawn
- 1985-08-23 PT PT81018A patent/PT81018B/pt unknown
- 1985-08-23 FI FI853255A patent/FI853255A7/fi not_active Application Discontinuation
- 1985-09-04 EG EG545/85A patent/EG17149A/xx active
Also Published As
| Publication number | Publication date |
|---|---|
| FI853255L (fi) | 1986-03-06 |
| FI853255A0 (fi) | 1985-08-23 |
| ES546285A0 (es) | 1986-09-01 |
| PH20796A (en) | 1987-04-14 |
| AU581918B2 (en) | 1989-03-09 |
| HU194181B (en) | 1988-01-28 |
| PT81018B (en) | 1987-06-24 |
| IL76100A0 (en) | 1985-12-31 |
| GR852041B (enEXAMPLES) | 1985-12-19 |
| DK379985A (da) | 1986-03-06 |
| ZW13385A1 (en) | 1985-11-20 |
| HUT38617A (en) | 1986-06-30 |
| EP0174118A3 (en) | 1986-12-30 |
| FI853255A7 (fi) | 1986-03-06 |
| NZ213141A (en) | 1988-07-28 |
| US4541954A (en) | 1985-09-17 |
| PT81018A (en) | 1985-09-01 |
| EG17149A (en) | 1989-06-30 |
| AU4648185A (en) | 1986-03-13 |
| ES8609266A1 (es) | 1986-09-01 |
| EP0174118A2 (en) | 1986-03-12 |
| DK379985D0 (da) | 1985-08-21 |
| NO853255L (no) | 1986-03-06 |
| KR860002470A (ko) | 1986-04-26 |
| JPS6168469A (ja) | 1986-04-08 |
| ZA856268B (en) | 1986-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1244017A (en) | Method for preparing 6-chloro-n-methyl-2,3,4,5- tetrahydro-1h-3-benzazepine | |
| EP2471780B1 (en) | Crystalline Ivabradine Oxalate Salts and Polymorphs Thereof | |
| EP1430008A2 (en) | Process for preparing pentacene derivatives | |
| US3639407A (en) | Novel 1 2 3 4 5 6-hexahydro-6-phenyl-2 6-methano-3-benzazocines | |
| EP0161350A1 (en) | Process for preparing benzazepines | |
| NZ234845A (en) | Dibenzothiazine derivatives and pharmaceutical compositions | |
| Monković et al. | Synthetic morphinans and hasubanans. Part IV. Total synthesis of 3, 14-dihydroxyisomorphinans, 3-methoxy-Δ8, 14-morphinans, and 9α-hydroxy-3-methoxyhasubanan | |
| US6500954B1 (en) | Synthesis of 5- or 8-bromoisoquinoline derivatives | |
| DE3688788T2 (de) | Benzazepinderivate. | |
| US4555570A (en) | Substituted 4-alkyl-2-(1H) quinazolinone-1-alkanoic acid derivatives | |
| US3549635A (en) | Preparation of substituted-2(1h)-quinazolinones | |
| GB2207427A (en) | Benzazepine derivatives | |
| EP0233049A1 (en) | 2,3,4,8,9,9a-Hexahydro-4-aryl-1H-indeno[1,7-cd]azepines | |
| US5571918A (en) | Method for producing 2-methylspiro(1,3-oxathiolane-5,3')quinuclidine | |
| KR100392060B1 (ko) | 5-ht2수용체에대한친화성을가진치환된테트라사이클릭아제핀유도체 | |
| JPH051071A (ja) | 抗アテローム性動脈硬化症フロクロモン | |
| EP0300074A1 (en) | Processes and intermediates useful in the preparation of Cis 1,3,4,6,7 llb-Hexa-hydro-7-aryl-2H-pyrazino[2,1-a]isoquinolines | |
| Kieran J áMallon | A synthesis of aaptamine from 6, 7-dimethoxy-1-methylisoquinoline | |
| CA1065871A (en) | Process for the production of oxygenated azatetracyclic compounds | |
| US3583997A (en) | Benzothiopyrano(2,3-c)pyridines | |
| EP0033632B1 (en) | 7,8-amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines, process for their preparation and pharmaceutical compositions containing them | |
| JP3531954B2 (ja) | ジルチアゼムの製造方法 | |
| EP0009284A1 (en) | Novel tetracyclic compounds, processes for their preparation and pharmaceutical compositions | |
| AU753563B2 (en) | Improved method for preparing pharmaceutically valuable norbenzomorphane derivatives | |
| DE60000560T2 (de) | Verfahren zur Herstellung einer sehr sauberen Phenotiazin Verbindung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |